Cargando…

Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based Imaging

SIMPLE SUMMARY: Breast cancer is the most frequent cancer affecting women and metastatic breast cancer is still the leading cause of death from all cancers in women, accounting for about 3.6% of all deaths in women. The N-stage represents the main prognostic factor affecting the rate of recurrence a...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Paola, Valerio, Mazzotta, Giorgio, Pignatelli, Vincenza, Bufi, Enida, D’Angelo, Anna, Conti, Marco, Panico, Camilla, Fiorentino, Vincenzo, Pierconti, Francesco, Kilburn-Toppin, Fleur, Belli, Paolo, Manfredi, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454572/
https://www.ncbi.nlm.nih.gov/pubmed/36077805
http://dx.doi.org/10.3390/cancers14174270
_version_ 1784785379926212608
author Di Paola, Valerio
Mazzotta, Giorgio
Pignatelli, Vincenza
Bufi, Enida
D’Angelo, Anna
Conti, Marco
Panico, Camilla
Fiorentino, Vincenzo
Pierconti, Francesco
Kilburn-Toppin, Fleur
Belli, Paolo
Manfredi, Riccardo
author_facet Di Paola, Valerio
Mazzotta, Giorgio
Pignatelli, Vincenza
Bufi, Enida
D’Angelo, Anna
Conti, Marco
Panico, Camilla
Fiorentino, Vincenzo
Pierconti, Francesco
Kilburn-Toppin, Fleur
Belli, Paolo
Manfredi, Riccardo
author_sort Di Paola, Valerio
collection PubMed
description SIMPLE SUMMARY: Breast cancer is the most frequent cancer affecting women and metastatic breast cancer is still the leading cause of death from all cancers in women, accounting for about 3.6% of all deaths in women. The N-stage represents the main prognostic factor affecting the rate of recurrence and the therapeutic management so that a correct staging of the axillary lymph node status is fundamental. Since clinical examination of the axillary cavity is associated with a high false negative rate, reaching values of 45%, the role of imaging becomes crucial to obtain an accurate assessment of loco-regional lymph nodes at the time of diagnosis. In this setting, Ultrasound and Magnetic Resonance Imaging (MRI) represent two important diagnostic tools. In particular, MRI represents an accurate and reproducible technique, which allows an accurate staging of the “N-stage”. ABSTRACT: The correct N-staging in breast cancer is crucial to tailor treatment and stratify the prognosis. N-staging is based on the number and the localization of suspicious regional nodes on physical examination and/or imaging. Since clinical examination of the axillary cavity is associated with a high false negative rate, imaging modalities play a central role. In the presence of a T1 or T2 tumor and 0–2 suspicious nodes, on imaging at the axillary level I or II, a patient should undergo sentinel lymph node biopsy (SLNB), whereas in the presence of three or more suspicious nodes at the axillary level I or II confirmed by biopsy, they should undergo axillary lymph node dissection (ALND) or neoadjuvant chemotherapy according to a multidisciplinary approach, as well as in the case of internal mammary, supraclavicular, or level III axillary involved lymph nodes. In this scenario, radiological assessment of lymph nodes at the time of diagnosis must be accurate. False positives may preclude a sentinel lymph node in an otherwise eligible woman; in contrast, false negatives may lead to an unnecessary SLNB and the need for a second surgical procedure. In this review, we aim to describe the anatomy of the axilla and breast regional lymph node, and their diagnostic features to discriminate between normal and pathological nodes at Ultrasound (US) and Magnetic Resonance Imaging (MRI). Moreover, the technical aspects, the advantage and limitations of MRI versus US, and the possible future perspectives are also analyzed, through the analysis of the recent literature.
format Online
Article
Text
id pubmed-9454572
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94545722022-09-09 Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based Imaging Di Paola, Valerio Mazzotta, Giorgio Pignatelli, Vincenza Bufi, Enida D’Angelo, Anna Conti, Marco Panico, Camilla Fiorentino, Vincenzo Pierconti, Francesco Kilburn-Toppin, Fleur Belli, Paolo Manfredi, Riccardo Cancers (Basel) Review SIMPLE SUMMARY: Breast cancer is the most frequent cancer affecting women and metastatic breast cancer is still the leading cause of death from all cancers in women, accounting for about 3.6% of all deaths in women. The N-stage represents the main prognostic factor affecting the rate of recurrence and the therapeutic management so that a correct staging of the axillary lymph node status is fundamental. Since clinical examination of the axillary cavity is associated with a high false negative rate, reaching values of 45%, the role of imaging becomes crucial to obtain an accurate assessment of loco-regional lymph nodes at the time of diagnosis. In this setting, Ultrasound and Magnetic Resonance Imaging (MRI) represent two important diagnostic tools. In particular, MRI represents an accurate and reproducible technique, which allows an accurate staging of the “N-stage”. ABSTRACT: The correct N-staging in breast cancer is crucial to tailor treatment and stratify the prognosis. N-staging is based on the number and the localization of suspicious regional nodes on physical examination and/or imaging. Since clinical examination of the axillary cavity is associated with a high false negative rate, imaging modalities play a central role. In the presence of a T1 or T2 tumor and 0–2 suspicious nodes, on imaging at the axillary level I or II, a patient should undergo sentinel lymph node biopsy (SLNB), whereas in the presence of three or more suspicious nodes at the axillary level I or II confirmed by biopsy, they should undergo axillary lymph node dissection (ALND) or neoadjuvant chemotherapy according to a multidisciplinary approach, as well as in the case of internal mammary, supraclavicular, or level III axillary involved lymph nodes. In this scenario, radiological assessment of lymph nodes at the time of diagnosis must be accurate. False positives may preclude a sentinel lymph node in an otherwise eligible woman; in contrast, false negatives may lead to an unnecessary SLNB and the need for a second surgical procedure. In this review, we aim to describe the anatomy of the axilla and breast regional lymph node, and their diagnostic features to discriminate between normal and pathological nodes at Ultrasound (US) and Magnetic Resonance Imaging (MRI). Moreover, the technical aspects, the advantage and limitations of MRI versus US, and the possible future perspectives are also analyzed, through the analysis of the recent literature. MDPI 2022-08-31 /pmc/articles/PMC9454572/ /pubmed/36077805 http://dx.doi.org/10.3390/cancers14174270 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Di Paola, Valerio
Mazzotta, Giorgio
Pignatelli, Vincenza
Bufi, Enida
D’Angelo, Anna
Conti, Marco
Panico, Camilla
Fiorentino, Vincenzo
Pierconti, Francesco
Kilburn-Toppin, Fleur
Belli, Paolo
Manfredi, Riccardo
Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based Imaging
title Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based Imaging
title_full Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based Imaging
title_fullStr Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based Imaging
title_full_unstemmed Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based Imaging
title_short Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based Imaging
title_sort beyond n staging in breast cancer: importance of mri and ultrasound-based imaging
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454572/
https://www.ncbi.nlm.nih.gov/pubmed/36077805
http://dx.doi.org/10.3390/cancers14174270
work_keys_str_mv AT dipaolavalerio beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT mazzottagiorgio beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT pignatellivincenza beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT bufienida beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT dangeloanna beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT contimarco beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT panicocamilla beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT fiorentinovincenzo beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT piercontifrancesco beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT kilburntoppinfleur beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT bellipaolo beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging
AT manfrediriccardo beyondnstaginginbreastcancerimportanceofmriandultrasoundbasedimaging